{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:21:14Z","timestamp":1780579274203,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clgc.2012.12.006","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T17:02:54Z","timestamp":1358355774000},"page":"357-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Translocation Renal Cell Carcinomas: An Evolving Entity and a Member of the Microphthalmia Transcription Factor-Associated Family of Tumors"],"prefix":"10.1016","volume":"11","author":[{"given":"Richard M.","family":"Bambury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie E.","family":"Battley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek G.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2012.12.006_bib1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib2","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1200\/JCO.2010.32.6223","article-title":"Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer","volume":"29","author":"Haq","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.12.006_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1309\/EAEJTJGD5J4J3B4F","article-title":"The evolving story of renal translocation carcinomas","volume":"126","author":"Argani","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.juro.2010.08.092","article-title":"Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors","volume":"185","author":"Malouf","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.12.006_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00313021003767348","article-title":"Xp11 translocation renal cell carcinoma","volume":"42","author":"Ross","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.clgc.2012.12.006_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0b013e31824f24a6","article-title":"Translocation renal cell carcinomas in adults: a single-institution experience","volume":"36","author":"Zhong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib7","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1002\/cncr.25512","article-title":"Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma","volume":"116","author":"Choueiri","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.12.006_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1309\/AJCPQ6LLFMC4OXGC","article-title":"Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis","volume":"137","author":"Klatte","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib9","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1200\/JCO.2009.26.8193","article-title":"Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma","volume":"28","author":"Kelly","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.12.006_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.ju.0000165572.38887.da","article-title":"Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system","volume":"174","author":"Lam","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.12.006_bib11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the juvenile RCC network","volume":"21","author":"Malouf","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2012.12.006_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib13","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1002\/cncr.27582","article-title":"Tivantinib (arq 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial","volume":"118","author":"Wagner","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.12.006_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11912-011-0159-y","article-title":"Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities","volume":"13","author":"Bex","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clgc.2012.12.006_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/PAS.0b013e31825aafb5","volume":"36","author":"Rao","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2012.12.006_bib16","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1200\/JCO.2010.31.8923","article-title":"American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy","volume":"29","author":"Keedy","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:23:24Z","timestamp":1761564204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767312002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1558767312002455"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2012.12.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translocation Renal Cell Carcinomas: An Evolving Entity and a Member of the Microphthalmia Transcription Factor-Associated Family of Tumors","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2012.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}